申请人:Gajewski Peter Robert
公开号:US20070105951A1
公开(公告)日:2007-05-10
The present invention relates to novel, non-secosteroidal, phenyl-furan compounds with vitamin D receptor (VDR) modulating activity that are less hypercalcemic than 1α,25dihydroxy vitamin D3. These compounds are useful for treating bone disease and psoriasis.
本发明涉及一种新型的非次生类固醇苯基呋喃化合物,具有维生素D受体(VDR)调节活性,其低于1α,25-二羟基维生素D3的高钙血症作用。这些化合物可用于治疗骨病和牛皮癣。